F

Flora Growth Corp
D

FLGC

0.88000
USD
0.01
(1.14%)
Market Closed
Volume
2,218
EPS
0
Div Yield
-
P/E
-1
Market Cap
16,016,565
Related Instruments
    B
    BALY
    -1.490
    (-8.40%)
    16.250 USD
    B
    BYD
    -2.530
    (-3.19%)
    76.870 USD
    C
    CRSR
    -0.710
    (-5.67%)
    11.820 USD
    C
    CZR
    -2.420
    (-6.41%)
    35.340 USD
    D
    DKNG
    -3.865
    (-7.82%)
    45.570 USD
    LVS
    LVS
    -0.950
    (-2.11%)
    44.030 USD
    M
    MGM
    -2.300
    (-6.01%)
    36.000 USD
    P
    PENN
    -0.405
    (-1.90%)
    20.915 USD
    R
    RSI
    -1.730
    (-11.23%)
    13.670 USD
    W
    WYNN
    -2.720
    (-2.91%)
    90.770 USD
    More
News

Title: Flora Growth Corp

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.